HI
CLOV icon

HBK Investments’s Clover Health Investments CLOV Stock Holding History

HBK Investments’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-500,000
Closed -$8.38M – 868
2020
Q4 		$8.38M Buy
+500,000
New +$5.57M 0.05% 150

Other funds holding CLOV

GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

HBK Investments's CLOV Position: Q1 2021 in Review

HBK Investments sold out of Clover Health Investments (CLOV) in Q1 2021, closing a stake of 500,000 shares — an estimated $8.38M sold.

HBK Investments first reported a position in CLOV in Q2 2020 and held it in 3 quarters. The position peaked at $14M in Q2 2020. 137 funds tracked by Wall St. Rank hold CLOV as of Q1 2021.

  • HBK Investments reported no remaining Clover Health Investments position as of Q1 2021 after selling out during the quarter.
  • HBK Investments sold 500,000 Clover Health Investments shares in Q1 2021, an estimated $8.38M.
  • HBK Investments first reported a position in Clover Health Investments in Q2 2020 and held it in 3 quarters.
  • HBK Investments's Clover Health Investments position peaked at $14M in Q2 2020.
  • 137 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2021.

Based on HBK Investments's 13F filing for Q1 2021, filed 17 May 2021.